Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
2,323,662
-
Share change
-
-743,764
-
Total reported value
-
$18,479,579
-
Price per share
-
$7.95
-
Number of holders
-
56
-
Value change
-
-$6,276,333
-
Number of buys
-
30
-
Number of sells
-
25
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q1 2025
As of 31 Mar 2025,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,323,662 shares.
The largest 10 holders included
One Capital Management, LLC, Portland Global Advisors LLC, FLOW TRADERS U.S. LLC, JANE STREET GROUP, LLC, BANK OF AMERICA CORP /DE/, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., LPL Financial LLC, TWO SIGMA INVESTMENTS, LP, IHT Wealth Management, LLC, and OPPENHEIMER ASSET MANAGEMENT INC..
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.